Inactive Instrument

News NPS Pharmaceuticals, Inc.

Equities

US62936P1030

End-of-day quote Nasdaq Other stock markets
- ^USD	-

2015	NPS Pharmaceuticals : Shire confident on 2015 after NPS deal, binge-eating drug approval	RE
2015	NPS Pharmaceuticals : Shire shares jump as drug approval vindicates $5.2 billion NPS purchase	RE

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

NPS Pharmaceuticals : Shire Completes Acquisition of NPS Pharma	15-02-21	PR
NPS Pharmaceuticals : Shire confident on 2015 after NPS deal, binge-eating drug approval	15-02-12	RE
NPS Pharmaceuticals : Biotech Stocks Review - Arena Pharma, Amgen, NPS Pharma, ZIOPHARM Oncology, and Advaxis	15-02-06	PR
NPS Pharmaceuticals : Shire shares jump as drug approval vindicates $5.2 billion NPS purchase	15-01-26	RE
NPS Pharmaceuticals : FDA Approves Natpara® (parathyroid hormone) for Injection as an Adjunct to Calcium and Vitamin D to Control Hypocalcemia in Patients with Hypoparathyroidism	15-01-23	BU
Aegerion Pharmaceuticals : Exclusive: Top investors push Aegerion to oust CEO, consider sale - sources	15-01-14	RE
NPS Pharmaceuticals : Ryan & Maniskas, LLP : Announces Investigation of NPS Pharmaceuticals, Inc.	15-01-13	PR
NPS Pharmaceuticals : Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of NPS Pharmaceuticals, Inc. Stockholders	15-01-12	BU
Alcoa : Wall St. falls; energy shares dragged down further by oil	15-01-12	RE
NPS Pharmaceuticals : PLShire to Acquire NPS Pharma as Further Step in Building a Leading Biotech	15-01-11	PR
NPS Pharmaceuticals : Pharma to Present at J.P. Morgan Healthcare Conference	15-01-05	BU
AbbVie : Shire considering bid for NPS Pharmaceuticals - Bloomberg	14-12-17	RE
NPS Pharmaceuticals : Pharma to Present at Oppenheimer Healthcare Conference	14-12-04	BU
NPS Pharmaceuticals : European Medicines Agency Validates Marketing Authorization Application for Natpar® (parathyroid hormone (rDNA)) in Hypoparathyroidism	14-12-02	BU
NPS Pharmaceuticals : Pharma to Present at Deutsche Bank BioFEST Conference	14-11-25	BU
NPS Pharmaceuticals : Teduglutide Granted Orphan Drug Designation in Japan	14-11-24	BU
NPS Pharmaceuticals : Pharma to Present at Jefferies Global Healthcare Conference	14-11-11	BU
NPS Pharmaceuticals : Pharma Reports Third-Quarter 2014 Financial Results	14-11-10	BU
NPS Pharmaceuticals : Pharma Appoints Pierre Legault to Board of Directors	14-11-04	BU
NPS Pharmaceuticals : Pharma to Report Third Quarter 2014 Financial Results	14-11-03	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News NPS Pharmaceuticals, Inc.

Equities

US62936P1030

Summary

Filters